Startups
Edit
CORE Biomedicine, Inc. --> CORE Biomedicine, Inc.
https://corebiomedicine.com/Last activity: 31.07.2026
Active
Reimagining Precision Medicine Through Cancer Lineage Therapeutics. We develop therapies that go beyond genomic alterations to target the core lineage pathways tumors depend on.
Overview
Total raised
$21M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 28, 2026 | CORE Biomedicine Scores $21M Series A | BOSTON, MA, CORE Biomedicine, a biotechnology company pioneering lineage-based precision oncology therapeutics, today announced the completion of a $21 million Series A financing. >> Click here for more funding data on CORE Biomedici... |
| CORE Biomedicine | “Core Biomedicine | Reimagining Precision Medicine Through Cancer Lineage Therapeutics” |
Reviews 0
FAQ about CORE Biomedicine, Inc. --> CORE Biomedicine, Inc.
How much funding has CORE Biomedicine, Inc. --> CORE Biomedicine, Inc. raised?
CORE Biomedicine, Inc. --> CORE Biomedicine, Inc. has raised $21M in total across 1 funding round.
What has the press written about CORE Biomedicine, Inc. --> CORE Biomedicine, Inc.?
Parsers VC has collected 3 articles mentioning CORE Biomedicine, Inc. --> CORE Biomedicine, Inc., among them “CORE Biomedicine Scores $21M Series A” (Jul 28, 2026) and “CORE Biomedicine”.
Is CORE Biomedicine, Inc. --> CORE Biomedicine, Inc. still active?
Yes, CORE Biomedicine, Inc. --> CORE Biomedicine, Inc. is active; its latest activity on Parsers VC dates from Jul 31, 2026.